Trial Profile
A prospective, observational study investigating the real-world utilization, patient reported outcomes, and treatment satisfaction among plaque psoriasis patients treated with ustekinumab, etanercept, or adalimumab
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2017
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Ustekinumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 09 Jun 2017 New trial record